[go: up one dir, main page]

RU2011111891A - METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS - Google Patents

METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS Download PDF

Info

Publication number
RU2011111891A
RU2011111891A RU2011111891/14A RU2011111891A RU2011111891A RU 2011111891 A RU2011111891 A RU 2011111891A RU 2011111891/14 A RU2011111891/14 A RU 2011111891/14A RU 2011111891 A RU2011111891 A RU 2011111891A RU 2011111891 A RU2011111891 A RU 2011111891A
Authority
RU
Russia
Prior art keywords
experimental animals
systemic amyloidosis
administered
protein preparation
prevention
Prior art date
Application number
RU2011111891/14A
Other languages
Russian (ru)
Other versions
RU2473134C2 (en
Inventor
Алина Таймуразовна Беликова (RU)
Алина Таймуразовна Беликова
Вадим Борисович Брин (RU)
Вадим Борисович Брин
Константин Мурадиевич Козырев (RU)
Константин Мурадиевич Козырев
Original Assignee
Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская ак
Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения и социального развития РФ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская ак, Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения и социального развития РФ filed Critical Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская ак
Priority to RU2011111891/14A priority Critical patent/RU2473134C2/en
Publication of RU2011111891A publication Critical patent/RU2011111891A/en
Application granted granted Critical
Publication of RU2473134C2 publication Critical patent/RU2473134C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ профилактики системного амилоидоза и его нефропатической формы у экспериментальных животных, включающий введение животным подкожно через день белкового препарата в определенной дозе и амилоидопротекторного препарата, отличающийся тем, что в качестве белкового препарата вводят нативную человеческую плазму сирийским хомякам из расчета 0,025 мл/г массы тела, а в качестве амилоидопротектора используют галавит, вводимый им, одновременно, в дозе 0,28 мг/кг в течение 60 дней эксперимента. A method for preventing systemic amyloidosis and its nephropathic form in experimental animals, comprising administering to the animals subcutaneously every other day a protein preparation in a specific dose and an amyloidoprotective drug, characterized in that native human plasma is administered to Syrian hamsters as a protein preparation at the rate of 0.025 ml / g body weight, and as an amyloidoprotector, galavit is used, administered at the same time at a dose of 0.28 mg / kg for 60 days of the experiment.

Claims (1)

Способ профилактики системного амилоидоза и его нефропатической формы у экспериментальных животных, включающий введение животным подкожно через день белкового препарата в определенной дозе и амилоидопротекторного препарата, отличающийся тем, что в качестве белкового препарата вводят нативную человеческую плазму сирийским хомякам из расчета 0,025 мл/г массы тела, а в качестве амилоидопротектора используют галавит, вводимый им, одновременно, в дозе 0,28 мг/кг в течение 60 дней эксперимента. A method for preventing systemic amyloidosis and its nephropathic form in experimental animals, comprising administering to the animals subcutaneously every other day a protein preparation in a specific dose and an amyloidoprotective drug, characterized in that native human plasma is administered to Syrian hamsters as a protein preparation at the rate of 0.025 ml / g body weight, and as an amyloidoprotector, galavit is used, administered at the same time at a dose of 0.28 mg / kg for 60 days of the experiment.
RU2011111891/14A 2011-03-29 2011-03-29 Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals RU2473134C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011111891/14A RU2473134C2 (en) 2011-03-29 2011-03-29 Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011111891/14A RU2473134C2 (en) 2011-03-29 2011-03-29 Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals

Publications (2)

Publication Number Publication Date
RU2011111891A true RU2011111891A (en) 2012-10-10
RU2473134C2 RU2473134C2 (en) 2013-01-20

Family

ID=47079009

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011111891/14A RU2473134C2 (en) 2011-03-29 2011-03-29 Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals

Country Status (1)

Country Link
RU (1) RU2473134C2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69013139T2 (en) * 1990-03-13 1995-05-18 Riha Means for the prevention, diagnosis and therapy of rheumatic, autoimmune, skin and connective tissue diseases of unknown etiology and methods for their preparation and use.
RU2270672C1 (en) * 2004-09-15 2006-02-27 Северо-Осетинская государственная медицинская академия Method for prophylaxis and treatment of systemic amyloidosis and nephropathic form thereof in experimental animals
WO2007125385A2 (en) * 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
RU2312663C1 (en) * 2006-02-21 2007-12-20 Закрытое акционерное общество "Центр современной медицины "Медикор" Method for treatment of acute destructive pancreatitis
RU2383342C1 (en) * 2008-07-16 2010-03-10 Наталья Эдуардовна Романцева Method of treating pulmonary tuberculosis in hiv-infection patients
RU2381797C1 (en) * 2008-11-05 2010-02-20 Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию Method for prevention of systemic amyloidosis and its nephropatic form in experimental animals

Also Published As

Publication number Publication date
RU2473134C2 (en) 2013-01-20

Similar Documents

Publication Publication Date Title
RU2016105581A (en) METHOD FOR TREATING ACUTE, CHRONIC AND SIMPLE COUGH AND IRREGULAR DESIRE
HK1221646A1 (en) Use of high dose pridopidine for treating huntington's disease
NZ714963A (en) Compositions and methods for treating anemia
RU2014150942A (en) TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE
EA201492010A1 (en) APPLICATION OF HIGH DOSE OF LACHINIMODE FOR TREATMENT OF MULTIPLE SCLEROSIS
RU2014102939A (en) Vaccine composition for transdermal administration
FI3383385T4 (en) Melflufen dosage regimens for cancer
JOP20190019A1 (en) Pharmaceutical Formula for Treatment of Growth Hormone Deficiency Contains Human Growth Hormone (hGH) Fusion Protein
RU2013108390A (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OF PERIOPERATIVE ARTERIAL HYPOTENSION IN HUMAN
RU2015112121A (en) MI-RNA AND THEIR APPLICATION IN METHODS AND COMPOSITIONS FOR TREATMENT AND / OR PREVENTION OF EYE CONDITIONS
EA201591653A1 (en) COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
RU2011111891A (en) METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS
RU2011112243A (en) METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS
RU2010153722A (en) METHOD FOR INCREASING EFFECTIVENESS OF TREATMENT OF HYPOFUNCTIONS OF OVARIES IN COWS
RU2011133838A (en) METHOD FOR INCREASING PIG PRODUCTIVITY
RU2010134265A (en) METHOD FOR TREATING DYSPEPSY IN CALVES
RU2014148062A (en) INJECTION PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL
EA201491841A1 (en) COMPOSITION OF ESMOLOL FOR PARENTERAL INTRODUCTION
RU2010146367A (en) METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS
RU2011108858A (en) MEANS FOR INCREASING GROWTH AND PRESERVATION OF YOUNG PEOPLE
NZ707246A (en) Uses of Bremelanotide in Therapy for Female Sexual Dysfunction
RU2011132202A (en) METHOD FOR IMPROVING CHICKENS
RU2013154562A (en) METHODS AND COMPOSITIONS FOR PRESERVING THE BEAUTY BODY WEIGHT IN THE PROCESS OF SLIMMING
RU2017138187A (en) A method of reducing the hypertensive effect of cobalt chloride calcitonin

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130330